drugset / Trial / NCT00019240

Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection

NCT00019240

Treatment

Summary

RATIONALE: Herpesvirus is found in Kaposi's sarcoma lesions in most patients; it is therefore possible that the herpesvirus has a role in causing Kaposi's sarcoma. Cidofovir is an antiviral drug that acts against many types of herpesvirus, and may be an effective treatment for Kaposi's sarcoma. PURPOSE: Phase II trial to study the effectiveness of cidofovir in treating patients with Kaposi's sarcoma with or without HIV infection.

Timeline

Start
1996-11
Primary completion
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CIDOFOVIR ANHYDROUS Small molecule Intravenous

Indications